Recent Study: Croatia Pharmaceuticals & Healthcare Report Q4 2013
The Croatian pharmaceutical market continues to pose a challenging environment to domestic and international drugmakers, but we believe EU accession will ease the regulatory burden as legislation is harmonised with EU norms. However, the imposition of across-the-board price cuts later in 2013 will weigh heavily on the pharmaceutical market. We forecast weak pharmaceutical market growth for the next decade due to the high levels of public debt and chronic liquidity issues within the healthcare system and pharmaceutical supply chain. Healthcare...
View full press release